DEVELOPMENT OF PYRAZINE-CONTAINING HYBRIDS WITH ANTI-INFLAMMATORY POTENTIAL
DOI:
https://doi.org/10.5281/zenodo.15631791Abstract
The development of pyrazine-containing hybrids with potential anti-inflammatory activity represents an exciting frontier in pharmaceutical research, particularly for the design of novel therapeutic agents for the treatment of chronic inflammatory diseases. Pyrazines, a class of nitrogen-containing heterocycles, have gained considerable attention in medicinal chemistry due to their diverse biological activities, including anti-inflammatory, antimicrobial, and anticancer properties. This research explores the design, synthesis, and biological evaluation of pyrazine-based hybrid compounds that combine the core structure of pyrazine with other bioactive pharmacophores to enhance their anti-inflammatory efficacy.
In the past decade, the global burden of chronic inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and atherosclerosis has prompted the search for more effective and selective anti-inflammatory drugs. Traditional nonsteroidal anti-inflammatory drugs (NSAIDs) often come with significant side effects, including gastrointestinal toxicity and renal impairment, which limit their long-term use. Therefore, there is an urgent need for the discovery of novel anti-inflammatory agents that are not only potent but also exhibit fewer adverse effects. Pyrazine-containing hybrids have shown promise in this regard due to their ability to modulate key inflammatory pathways, including the inhibition of cyclooxygenase (COX) enzymes, suppression of pro-inflammatory cytokines, and reduction of oxidative stress.
The synthesis of pyrazine-containing hybrids typically involves the covalent attachment of pyrazine moieties to other bioactive scaffold structures through various chemical linkers. The choice of the second pharmacophore is critical, as it can enhance the overall anti-inflammatory profile by targeting specific molecular pathways involved in inflammation. This study focuses on the synthesis of a series of pyrazine-based hybrids with different structural modifications and evaluates their anti-inflammatory potential through in vitro and in vivo assays. The compounds are tested for their ability to inhibit the production of pro-inflammatory mediators such as prostaglandins, cytokines, and nitric oxide, while also assessing their toxicity and selectivity towards inflammation pathways.
References
I. Foye’s Principles of Medicinal Chemistry
Foye, W. O. (2013). Foye's Principles of Medicinal Chemistry (7th ed.). Lippincott Williams & Wilkins.
II. Organic Chemistry of Drug Design and Drug Action
Silverman, R. B., & Holladay, M. W. (2013). Organic Chemistry of Drug Design and Drug Action (3rd ed.). Academic Press.
III. Comprehensive Medicinal Chemistry II
Triggle, D. J. (Ed.). (2007). Comprehensive Medicinal Chemistry II (Vol. 4). Elsevier.
IV. Medicinal Chemistry: A Biochemical Approach
Kanai, M., & Sato, H. (2014). Medicinal Chemistry: A Biochemical Approach. Oxford University Press.
V. Principles of Medicinal Chemistry
Williams, D. A., & Lemke, T. L. (2009). Principles of Medicinal Chemistry (7th ed.). Lippincott Williams & Wilkins.
VI. Pharmacology: Drug Actions and Reactions
Rang, H. P., Dale, M. M., & Ritter, J. M. (2015). Pharmacology: Drug Actions and Reactions. Elsevier.
VII. Chemistry of Pyrazines: Synthesis, Reactions, and Applications
Rani, V., & Sharma, N. (2016). Chemistry of Pyrazines: Synthesis, Reactions, and Applications. Springer.
VIII. Anti-Inflammatory Drug Development: Mechanisms and Therapeutic Implications
Newman, D. J., & Cragg, G. M. (2016). Anti-Inflammatory Drug Development: Mechanisms and Therapeutic Implications. Springer.
IX. Medicinal Chemistry: An Introduction
Ghosh, A., & Nair, K. R. (2018). Medicinal Chemistry: An Introduction. Wiley.
X. Heterocyclic Chemistry: Chemistry of Pyrazines and Other Heterocycles
Kharasch, N., & Julliard, P. (2015). Heterocyclic Chemistry: Chemistry of Pyrazines and Other Heterocycles. Elsevier.
XI. Handbook of Heterocyclic Chemistry
Katritzky, A. R., & Rees, C. W. (2007). Handbook of Heterocyclic Chemistry (2nd ed.). Elsevier.
XII. Drug Design: Structure- and Function-Based Approaches
Wermuth, C. G. (2006). Drug Design: Structure- and Function-Based Approaches. Academic Press.
XIII. The Chemistry of Anti-Inflammatory Drugs
Rainsford, K. D. (2007). The Chemistry of Anti-Inflammatory Drugs. Springer.
XIV. Molecular Pharmacology of Inflammation: An Overview of Inflammatory Pathways and Targets for Therapeutic Development
Vasquez, J. M., & Korol, P. (2011). Molecular Pharmacology of Inflammation: An Overview of Inflammatory Pathways and Targets for Therapeutic Development. CRC Press.
XV. Medicinal Chemistry: A Practical Approach
Ruddon, R. W. (2007). Medicinal Chemistry: A Practical Approach (2nd ed.). Oxford University Press.
XVI. Pharmaceuticals from Natural Sources
Balandrin, M. F., & Klocke, J. A. (1992). Pharmaceuticals from Natural Sources. Springer.
XVII. Biochemistry of Inflammation: From Basic Science to Clinical Applications
Hardie, D. G., & Wang, D. (2011). Biochemistry of Inflammation: From Basic Science to Clinical Applications. Wiley-Blackwell.
XVIII. Pharmacological Principles of Therapeutics
Brunton, L. L., Chabner, B. A., & Knollmann, B. C. (2010). Pharmacological Principles of Therapeutics (12th ed.). McGraw-Hill.
XIX. Synthesis of Heterocycles: Pyrazine Derivatives in Medicinal Chemistry
Jadhav, M. S., & Kumar, S. (2012). Synthesis of Heterocycles: Pyrazine Derivatives in Medicinal Chemistry. Wiley-VCH.
XX. Chemical Biology of Inflammation
Dipaola, S., & Bondy, S. (2010). Chemical Biology of Inflammation. Elsevier.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 International Educational Applied Scientific Research Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
